Literature DB >> 24203054

Coagulation, protease-activated receptors, and viral myocarditis.

Silvio Antoniak1, Nigel Mackman.   

Abstract

The coagulation protease cascade plays an essential role in hemostasis. In addition, a clot contributes to host defense by limiting the spread of pathogens. Coagulation proteases induce intracellular signaling by cleavage of cell surface receptors called protease-activated receptors (PARs). These receptors allow cells to sense changes in the extracellular environment, such as infection. Viruses activate the coagulation cascade by inducing tissue factor expression and by disrupting the endothelium. Virus infection of the heart can cause myocarditis, cardiac remodeling, and heart failure. A recent study using a mouse model have shown that tissue factor, thrombin, and PAR-1 signaling all positively regulate the innate immune during viral myocarditis. In contrast, PAR-2 signaling was found to inhibit interferon-β expression and the innate immune response. These observations suggest that anticoagulants may impair the innate immune response to viral infection and that inhibition of PAR-2 may be a new strategy to reduce viral myocarditis.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 24203054      PMCID: PMC3943797          DOI: 10.1007/s12265-013-9515-7

Source DB:  PubMed          Journal:  J Cardiovasc Transl Res        ISSN: 1937-5387            Impact factor:   4.132


  114 in total

Review 1.  Whatever turns you on: accessory-cell-dependent activation of NK cells by pathogens.

Authors:  Kirsty C Newman; Eleanor M Riley
Journal:  Nat Rev Immunol       Date:  2007-04       Impact factor: 53.106

Review 2.  Protease-activated receptors: novel PARtners in innate immunity.

Authors:  V Shpacovitch; M Feld; N W Bunnett; M Steinhoff
Journal:  Trends Immunol       Date:  2007-10-30       Impact factor: 16.687

3.  Single-stranded polyinosinic acid oligonucleotides trigger leukocyte production of proteins belonging to fibrinolytic and coagulation cascades.

Authors:  Fariba Zare; Mattias Magnusson; Linda Nilsson Möllers; Tao Jin; Andrej Tarkowski; Maria Bokarewa
Journal:  J Leukoc Biol       Date:  2008-06-18       Impact factor: 4.962

4.  Viral cysteine proteases are homologous to the trypsin-like family of serine proteases: structural and functional implications.

Authors:  J F Bazan; R J Fletterick
Journal:  Proc Natl Acad Sci U S A       Date:  1988-11       Impact factor: 11.205

5.  [Increased thrombocyte activation in dilated cardiomyopathy: a risk factor for development of ventricular thrombosis despite anticoagulant therapy?].

Authors:  U Weikert; U Rauch; U Kühl; C Hohmann; M Jaster; M Pauschinger; P L Schwimmbeck; H P Schultheiss
Journal:  Z Kardiol       Date:  2002-05

6.  Inhibitors of tryptase as mast cell-stabilizing agents in the human airways: effects of tryptase and other agonists of proteinase-activated receptor 2 on histamine release.

Authors:  Shaoheng He; Akhmed Aslam; Marianna D A Gaça; Yongsong He; Mark G Buckley; Morley D Hollenberg; Andrew F Walls
Journal:  J Pharmacol Exp Ther       Date:  2004-01-13       Impact factor: 4.030

Review 7.  Role of tissue factor in hemostasis and thrombosis.

Authors:  Nigel Mackman
Journal:  Blood Cells Mol Dis       Date:  2006-02-07       Impact factor: 3.039

Review 8.  Fibrin and fibrinolysis in infection and host defense.

Authors:  J L Degen; T H Bugge; J D Goguen
Journal:  J Thromb Haemost       Date:  2007-07       Impact factor: 5.824

Review 9.  Risks versus benefits of NSAIDs including aspirin in myocarditis: a review of the evidence from animal studies.

Authors:  Christophe Meune; Christian Spaulding; Isabelle Mahé; Pierre Lebon; Jean-François Bergmann
Journal:  Drug Saf       Date:  2003       Impact factor: 5.606

10.  Up-regulation of ectopic trypsins in the myocardium by influenza A virus infection triggers acute myocarditis.

Authors:  Hai-Yan Pan; Hirotsugu Yamada; Junji Chida; Siye Wang; Mihiro Yano; Min Yao; Jianhua Zhu; Hiroshi Kido
Journal:  Cardiovasc Res       Date:  2010-11-16       Impact factor: 10.787

View more
  20 in total

Review 1.  Review and Updates in Regenerative and Personalized Medicine, Preclinical Animal Models, and Clinical Care in Cardiovascular Medicine.

Authors:  Emanuele Barbato; Paul J Barton; Jozef Bartunek; Sally Huber; Borja Ibanez; Daniel P Judge; Enrique Lara-Pezzi; Craig M Stolen; Angela Taylor; Jennifer L Hall
Journal:  J Cardiovasc Transl Res       Date:  2015-10-09       Impact factor: 4.132

2.  Roles of PAR1 and PAR2 in viral myocarditis.

Authors:  Nigel Mackman; Silvio Antoniak
Journal:  Thromb Res       Date:  2014-05       Impact factor: 3.944

Review 3.  Multiple roles of the coagulation protease cascade during virus infection.

Authors:  Silvio Antoniak; Nigel Mackman
Journal:  Blood       Date:  2014-03-14       Impact factor: 22.113

4.  Protease-activated receptor 1 activation enhances doxorubicin-induced cardiotoxicity.

Authors:  Silvio Antoniak; Kohei Tatsumi; Clare M Schmedes; Steven P Grover; Rafal Pawlinski; Nigel Mackman
Journal:  J Mol Cell Cardiol       Date:  2018-08-10       Impact factor: 5.000

5.  Protease-Activated Receptor 1 Contributes to Angiotensin II-Induced Cardiovascular Remodeling and Inflammation.

Authors:  Silvio Antoniak; Jessica C Cardenas; Laura J Buczek; Frank C Church; Nigel Mackman; Rafal Pawlinski
Journal:  Cardiology       Date:  2016-11-24       Impact factor: 1.869

6.  Host genetic diversity enables Ebola hemorrhagic fever pathogenesis and resistance.

Authors:  Angela L Rasmussen; Atsushi Okumura; Martin T Ferris; Richard Green; Friederike Feldmann; Sara M Kelly; Dana P Scott; David Safronetz; Elaine Haddock; Rachel LaCasse; Matthew J Thomas; Pavel Sova; Victoria S Carter; Jeffrey M Weiss; Darla R Miller; Ginger D Shaw; Marcus J Korth; Mark T Heise; Ralph S Baric; Fernando Pardo-Manuel de Villena; Heinz Feldmann; Michael G Katze
Journal:  Science       Date:  2014-10-30       Impact factor: 47.728

7.  Protease-Activated Receptor 1 Enhances Poly I:C Induction of the Antiviral Response in Macrophages and Mice.

Authors:  Silvio Antoniak; Kohei Tatsumi; Michael Bode; Swetha Vanja; Julie C Williams; Nigel Mackman
Journal:  J Innate Immun       Date:  2016-11-08       Impact factor: 7.349

Review 8.  Tissue factor, protease activated receptors and pathologic heart remodelling.

Authors:  Silvio Antoniak; Erica Sparkenbaugh; Rafal Pawlinski
Journal:  Thromb Haemost       Date:  2014-08-07       Impact factor: 5.249

9.  Panax Notoginseng Saponins Ameliorates Coxsackievirus B3-Induced Myocarditis by Activating the Cystathionine-γ-Lyase/Hydrogen Sulfide Pathway.

Authors:  Lulu Pan; Yuanhai Zhang; Jiacheng Lu; Zhimin Geng; Lianhong Jia; Xing Rong; Zhenquan Wang; Qifeng Zhao; Rongzhou Wu; Maoping Chu; Chunxiang Zhang
Journal:  J Cardiovasc Transl Res       Date:  2015-11-02       Impact factor: 4.132

10.  Effect of AMP-activated protein kinase activation on cardiac fibroblast proliferation induced by coxsackievirus B3.

Authors:  Shengyang Jiang; Shunli Tian; Xueming Wu; Yijia Tao; Donglin Jiang
Journal:  Exp Ther Med       Date:  2016-03-18       Impact factor: 2.447

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.